Shonan Health Innovation Park

湘南アイパークの COVID-19 対策

In order to protect the health of residents, members, and visitors, Shonan iPark is taking all possible measures to prevent the spread of COVID-19 infection. We appreciate your corporation.

Shonan iPark hosted a panel discussion at BIO Digital 2020

Shonan iPark Introduction Movie

Presentation by Toshio Fujimoto

Session 1

What are the common traits of global innovation ecosystems?

Session 2

What are the current challenges and opportunities amid COVID-19?

Session 3

What is the new normal for innovation ecosystems?

Movies

5:48

2:42

3:12

NEWS

[2020.05.24]

【Article】5th article "Life Science VC Funding in Japan: Signs of Growth & Untapped Opportunities" by Toshio Fujimoto, General Manager of Shonan iPark, has been published on PharmaBoardroom.

[2021.04.21]

【Press Release】Muraoka-Fukasawa District Transforms into Cutting-Edge Center for Health Innovation

[2021.04.15]

【Press Release】New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry

[2021.04.06]

【Press Release】Shonan iPark Signs Partnership Agreement with UK Science Ecosystem, via the National Horizons Centre

[2021.02.02]

【Press Release】Shonan iPark Initiates Pilot Program for Development of iPS Cell Delivery Platform

[2021.01.21]

【Event Report】The summary report of the online event "Innovation and sustainability in Japan’s healthcare system", held on November 25 hosted by The Economist, in which iPark General Manager Fujimoto participated, is now available for download.

Click here to read the white paper "Supporting an Innovative Life Science Ecosystem in Japan" published by The Economist.
*General Manager Fujimoto cooperated in the interview as an expert.

Click here for past news